Fortis Healthcare Limited has issued a comprehensive postal ballot notice to shareholders seeking approval for its new Employee Stock Option Scheme 2026, marking a significant step in the company's talent retention and incentivization strategy.

Postal Ballot Notice Details

The company sent the postal ballot notice on February 16, 2026, to all shareholders in compliance with Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The notice seeks shareholder approval through special resolutions for three interconnected proposals related to the ESOP 2026 implementation.

Employee Stock Option Scheme 2026 Framework

The proposed ESOP 2026 represents a comprehensive employee incentivization program designed to attract and retain high-quality talent while aligning employee interests with shareholder value creation. The scheme covers eligible employees across the company, its subsidiaries, and associate companies.

Key Scheme Features

Three Special Resolutions for Approval

The postal ballot seeks approval for three distinct but related special resolutions:

Resolution 1: Approval of the Fortis Healthcare Limited Employee Stock Option Scheme 2026 for the company's direct employees and directors (excluding promoters, promoter group members, independent directors, and those holding more than 10% equity).

Resolution 2: Authorization to grant stock options to eligible employees of subsidiary companies under the same scheme framework.

Resolution 3: Authorization to grant stock options to eligible employees of associate companies under the ESOP 2026.

Eligibility and Implementation Structure

The scheme encompasses employees working exclusively with the company, subsidiaries, or associates, whether in India or internationally. The eligibility framework specifically excludes promoters, promoter group members, independent directors, and directors holding more than 10% of outstanding equity shares.

The Nomination and Remuneration Committee, designated as the Compensation Committee, will administer the scheme in accordance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The committee approved the ESOP 2026 on February 11, 2026, followed by Board approval on February 13, 2026.

Voting Process and Timeline

Shareholders can participate through remote e-voting facilitated by KFin Technologies Limited or traditional postal ballot forms. The company emphasizes that shareholders can use only one voting mode, with e-voting taking precedence if both methods are used.

The voting process accommodates both demat and physical shareholding modes, with detailed instructions provided for accessing various depository platforms including NSDL and CDSL systems.

Strategic Rationale

According to the explanatory statement, the company demonstrated commendable financial performance with robust revenue growth and improved profitability metrics. The ESOP 2026 aims to maintain competitiveness in the talent market while driving high-performance culture through equity participation aligned with long-term business objectives.

The scheme builds upon the company's previous employee stock option plans from 2007 and 2011, reflecting continued commitment to employee ownership and retention strategies.

Source:

Fortis Healthcare Limited has completed the mandatory newspaper publication of its Q3 FY26 unaudited financial results under SEBI regulations, following the company's strong financial performance for the quarter ended December 31, 2025. The healthcare giant reported consolidated revenues of INR 2,265 Cr, marking a significant 17.5% increase compared to Q3 FY25.

Regulatory Compliance and Publication Details

Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published its financial results on February 14, 2026, in English daily "Financial Express" (all editions) and Punjabi daily "Rozana Spokesman" (Mohali edition). The publication ensures transparency and accessibility of financial information to all stakeholders.

Strong Financial Performance Highlights

The consolidated financial results showcase robust operational efficiency across both hospital and diagnostics businesses, with significant margin expansion and revenue growth.

For the nine-month period ended December 31, 2025, consolidated revenues reached INR 6,809.44 Cr, demonstrating consistent growth momentum. The company's debt-equity ratio stood at 0.35 times, reflecting a balanced capital structure.

Hospital Business Drives Growth

The hospital business segment emerged as the primary growth driver, with revenues increasing substantially and margins improving across key specialties.

Corporate Governance and Transparency

The newspaper publication reflects Fortis Healthcare's commitment to regulatory compliance and stakeholder transparency. Company Secretary Satyendra Chauhan digitally signed the compliance documents on February 14, 2026, ensuring proper documentation and regulatory adherence.

The published financial statements include both standalone and consolidated results, providing comprehensive insights into the company's performance across all business verticals. The results demonstrate the company's strategic focus on operational excellence and sustainable growth in the healthcare sector.